Cell Death Discovery-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2192675, encodeId=d23d21926e582, content=审稿速度:12.0 经验分享：2023年7月投稿 一审73天 二审（包含元旦）73天 临时接收到正式接收 29天 可以说很慢了，急着毕业不推荐 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e592182462, createdName=12077503m07(暂无昵称), createdTime=Tue Mar 12 01:03:15 CST 2024, time=2024-03-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185091, encodeId=6ca521850918c, content=审稿速度:1.0 经验分享：一篇综述原则性接收了总体来说挺快的 23.10.23 提交 23.10.24 第一次under consideration 23.11.13 第二次under consideration 23.11.18 Decision Made 23.11.20 send author 24.1.14 修回 24.1.15 第一次under consideration 24.1.15 第二次under consideration 24.1.26 Decision Made 24.1.30 原则性接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Wed Jan 31 20:04:17 CST 2024, time=2024-01-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：Cddise转投过来的，9天decision made，不知道是什么结果，这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147415, encodeId=da21214e41547, content=这是被拒了吗，各位大佬。 Decision Sent to Author 10th Jul 23 11:06:21 Decision Made 7th Jul 23 17:45:06 Manuscript Under Consideration 28th Jun 23 11:12:00 Editor Assigned 26th Jun 23 03:06:10 Manuscript Received 26th Jun 23 03:06:10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dd36413313, createdName=ms4000001018877960, createdTime=Tue Jul 11 08:11:13 CST 2023, time=2023-07-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1053865, encodeId=7e1b105386582, content=7月31号投稿，9月22号还在Manuscript Under Consideration，这速度真的不算快了，另外我同学也投的这个，连外审邮件都没收到，半个月就1审完了，真的神秘, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5daf5161008, createdName=146b8015m10(暂无昵称), createdTime=Wed Sep 22 17:23:02 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127820, encodeId=7873212e82037, content=审稿速度:6.0 经验分享：太慢了，着急毕业强烈不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f325294363, createdName=1486df0cm29(暂无昵称), createdTime=Sun Apr 23 13:38:58 CST 2023, time=2023-04-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2114337, encodeId=c0eb211433e5e, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：请问各位老师朋友，从从ccdisease 转投过来，第七天发邮件分配副编辑，现在第25天系统里没有出现zip包，请问现在是送外审没有呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8062163824, createdName=正宗椰汁, createdTime=Mon Feb 13 09:03:18 CST 2023, time=2023-02-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1225664, encodeId=3f32122566451, content=偏重的研究方向：机制 经验分享：请问大家，cell death disease被拒并提出了审稿意见，联系转投cell death discovery，是需要按照审稿意见修改之后再转投还是直接投啊，还需要再次送外审吗？🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac0c8174562, createdName=ms2000001143063837, createdTime=Fri Jun 10 14:57:16 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186052, encodeId=b34621860529f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问CDDisease一审转投的话会不会有容易中啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 05 19:34:04 CST 2024, time=2024-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183621, encodeId=ebe5218362128, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：RNA 经验分享：请问下大家，版面费和published online，有先后顺序吗，是必须先缴费，才能给我文章online？我的只是发过来缴费邮件了，还没有看见online的邮件。我看我师妹的springer nature旗下某个期刊，是先online，然后30天内缴费，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5885600491, createdName=路过人间, createdTime=Wed Jan 24 09:59:43 CST 2024, time=2024-01-24, status=1, ipAttribution=江苏省)]

2024-03-12 12077503m07(暂无昵称) 来自湖北省

审稿速度:12.0
经验分享：2023年7月投稿
一审73天
二审（包含元旦）73天
临时接收到正式接收 29天

可以说很慢了，急着毕业不推荐

20 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192675, encodeId=d23d21926e582, content=审稿速度:12.0 经验分享：2023年7月投稿 一审73天 二审（包含元旦）73天 临时接收到正式接收 29天 可以说很慢了，急着毕业不推荐 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e592182462, createdName=12077503m07(暂无昵称), createdTime=Tue Mar 12 01:03:15 CST 2024, time=2024-03-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185091, encodeId=6ca521850918c, content=审稿速度:1.0 经验分享：一篇综述原则性接收了总体来说挺快的 23.10.23 提交 23.10.24 第一次under consideration 23.11.13 第二次under consideration 23.11.18 Decision Made 23.11.20 send author 24.1.14 修回 24.1.15 第一次under consideration 24.1.15 第二次under consideration 24.1.26 Decision Made 24.1.30 原则性接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Wed Jan 31 20:04:17 CST 2024, time=2024-01-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：Cddise转投过来的，9天decision made，不知道是什么结果，这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147415, encodeId=da21214e41547, content=这是被拒了吗，各位大佬。 Decision Sent to Author 10th Jul 23 11:06:21 Decision Made 7th Jul 23 17:45:06 Manuscript Under Consideration 28th Jun 23 11:12:00 Editor Assigned 26th Jun 23 03:06:10 Manuscript Received 26th Jun 23 03:06:10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dd36413313, createdName=ms4000001018877960, createdTime=Tue Jul 11 08:11:13 CST 2023, time=2023-07-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1053865, encodeId=7e1b105386582, content=7月31号投稿，9月22号还在Manuscript Under Consideration，这速度真的不算快了，另外我同学也投的这个，连外审邮件都没收到，半个月就1审完了，真的神秘, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5daf5161008, createdName=146b8015m10(暂无昵称), createdTime=Wed Sep 22 17:23:02 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127820, encodeId=7873212e82037, content=审稿速度:6.0 经验分享：太慢了，着急毕业强烈不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f325294363, createdName=1486df0cm29(暂无昵称), createdTime=Sun Apr 23 13:38:58 CST 2023, time=2023-04-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2114337, encodeId=c0eb211433e5e, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：请问各位老师朋友，从从ccdisease 转投过来，第七天发邮件分配副编辑，现在第25天系统里没有出现zip包，请问现在是送外审没有呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8062163824, createdName=正宗椰汁, createdTime=Mon Feb 13 09:03:18 CST 2023, time=2023-02-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1225664, encodeId=3f32122566451, content=偏重的研究方向：机制 经验分享：请问大家，cell death disease被拒并提出了审稿意见，联系转投cell death discovery，是需要按照审稿意见修改之后再转投还是直接投啊，还需要再次送外审吗？🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac0c8174562, createdName=ms2000001143063837, createdTime=Fri Jun 10 14:57:16 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186052, encodeId=b34621860529f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问CDDisease一审转投的话会不会有容易中啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 05 19:34:04 CST 2024, time=2024-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183621, encodeId=ebe5218362128, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：RNA 经验分享：请问下大家，版面费和published online，有先后顺序吗，是必须先缴费，才能给我文章online？我的只是发过来缴费邮件了，还没有看见online的邮件。我看我师妹的springer nature旗下某个期刊，是先online，然后30天内缴费，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5885600491, createdName=路过人间, createdTime=Wed Jan 24 09:59:43 CST 2024, time=2024-01-24, status=1, ipAttribution=江苏省)]

2024-01-31 ms6000001563747786 来自江西省

审稿速度:1.0
经验分享：一篇综述原则性接收了总体来说挺快的 23.10.23 提交 23.10.24 第一次under consideration 23.11.13 第二次under consideration 23.11.18 Decision Made 23.11.20 send author 24.1.14 修回 24.1.15 第一次under consideration 24.1.15 第二次under consideration 24.1.26 Decision Made 24.1.30 原则性接收

27 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192675, encodeId=d23d21926e582, content=审稿速度:12.0 经验分享：2023年7月投稿 一审73天 二审（包含元旦）73天 临时接收到正式接收 29天 可以说很慢了，急着毕业不推荐 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e592182462, createdName=12077503m07(暂无昵称), createdTime=Tue Mar 12 01:03:15 CST 2024, time=2024-03-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185091, encodeId=6ca521850918c, content=审稿速度:1.0 经验分享：一篇综述原则性接收了总体来说挺快的 23.10.23 提交 23.10.24 第一次under consideration 23.11.13 第二次under consideration 23.11.18 Decision Made 23.11.20 send author 24.1.14 修回 24.1.15 第一次under consideration 24.1.15 第二次under consideration 24.1.26 Decision Made 24.1.30 原则性接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Wed Jan 31 20:04:17 CST 2024, time=2024-01-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：Cddise转投过来的，9天decision made，不知道是什么结果，这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147415, encodeId=da21214e41547, content=这是被拒了吗，各位大佬。 Decision Sent to Author 10th Jul 23 11:06:21 Decision Made 7th Jul 23 17:45:06 Manuscript Under Consideration 28th Jun 23 11:12:00 Editor Assigned 26th Jun 23 03:06:10 Manuscript Received 26th Jun 23 03:06:10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dd36413313, createdName=ms4000001018877960, createdTime=Tue Jul 11 08:11:13 CST 2023, time=2023-07-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1053865, encodeId=7e1b105386582, content=7月31号投稿，9月22号还在Manuscript Under Consideration，这速度真的不算快了，另外我同学也投的这个，连外审邮件都没收到，半个月就1审完了，真的神秘, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5daf5161008, createdName=146b8015m10(暂无昵称), createdTime=Wed Sep 22 17:23:02 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127820, encodeId=7873212e82037, content=审稿速度:6.0 经验分享：太慢了，着急毕业强烈不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f325294363, createdName=1486df0cm29(暂无昵称), createdTime=Sun Apr 23 13:38:58 CST 2023, time=2023-04-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2114337, encodeId=c0eb211433e5e, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：请问各位老师朋友，从从ccdisease 转投过来，第七天发邮件分配副编辑，现在第25天系统里没有出现zip包，请问现在是送外审没有呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8062163824, createdName=正宗椰汁, createdTime=Mon Feb 13 09:03:18 CST 2023, time=2023-02-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1225664, encodeId=3f32122566451, content=偏重的研究方向：机制 经验分享：请问大家，cell death disease被拒并提出了审稿意见，联系转投cell death discovery，是需要按照审稿意见修改之后再转投还是直接投啊，还需要再次送外审吗？🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac0c8174562, createdName=ms2000001143063837, createdTime=Fri Jun 10 14:57:16 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186052, encodeId=b34621860529f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问CDDisease一审转投的话会不会有容易中啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 05 19:34:04 CST 2024, time=2024-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183621, encodeId=ebe5218362128, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：RNA 经验分享：请问下大家，版面费和published online，有先后顺序吗，是必须先缴费，才能给我文章online？我的只是发过来缴费邮件了，还没有看见online的邮件。我看我师妹的springer nature旗下某个期刊，是先online，然后30天内缴费，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5885600491, createdName=路过人间, createdTime=Wed Jan 24 09:59:43 CST 2024, time=2024-01-24, status=1, ipAttribution=江苏省)]

2024-02-19 ms5000001629270806 来自上海

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：Cddise转投过来的，9天decision made，不知道是什么结果，这也太快了吧😂

23 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192675, encodeId=d23d21926e582, content=审稿速度:12.0 经验分享：2023年7月投稿 一审73天 二审（包含元旦）73天 临时接收到正式接收 29天 可以说很慢了，急着毕业不推荐 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e592182462, createdName=12077503m07(暂无昵称), createdTime=Tue Mar 12 01:03:15 CST 2024, time=2024-03-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185091, encodeId=6ca521850918c, content=审稿速度:1.0 经验分享：一篇综述原则性接收了总体来说挺快的 23.10.23 提交 23.10.24 第一次under consideration 23.11.13 第二次under consideration 23.11.18 Decision Made 23.11.20 send author 24.1.14 修回 24.1.15 第一次under consideration 24.1.15 第二次under consideration 24.1.26 Decision Made 24.1.30 原则性接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Wed Jan 31 20:04:17 CST 2024, time=2024-01-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：Cddise转投过来的，9天decision made，不知道是什么结果，这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147415, encodeId=da21214e41547, content=这是被拒了吗，各位大佬。 Decision Sent to Author 10th Jul 23 11:06:21 Decision Made 7th Jul 23 17:45:06 Manuscript Under Consideration 28th Jun 23 11:12:00 Editor Assigned 26th Jun 23 03:06:10 Manuscript Received 26th Jun 23 03:06:10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dd36413313, createdName=ms4000001018877960, createdTime=Tue Jul 11 08:11:13 CST 2023, time=2023-07-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1053865, encodeId=7e1b105386582, content=7月31号投稿，9月22号还在Manuscript Under Consideration，这速度真的不算快了，另外我同学也投的这个，连外审邮件都没收到，半个月就1审完了，真的神秘, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5daf5161008, createdName=146b8015m10(暂无昵称), createdTime=Wed Sep 22 17:23:02 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127820, encodeId=7873212e82037, content=审稿速度:6.0 经验分享：太慢了，着急毕业强烈不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f325294363, createdName=1486df0cm29(暂无昵称), createdTime=Sun Apr 23 13:38:58 CST 2023, time=2023-04-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2114337, encodeId=c0eb211433e5e, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：请问各位老师朋友，从从ccdisease 转投过来，第七天发邮件分配副编辑，现在第25天系统里没有出现zip包，请问现在是送外审没有呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8062163824, createdName=正宗椰汁, createdTime=Mon Feb 13 09:03:18 CST 2023, time=2023-02-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1225664, encodeId=3f32122566451, content=偏重的研究方向：机制 经验分享：请问大家，cell death disease被拒并提出了审稿意见，联系转投cell death discovery，是需要按照审稿意见修改之后再转投还是直接投啊，还需要再次送外审吗？🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac0c8174562, createdName=ms2000001143063837, createdTime=Fri Jun 10 14:57:16 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186052, encodeId=b34621860529f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问CDDisease一审转投的话会不会有容易中啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 05 19:34:04 CST 2024, time=2024-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183621, encodeId=ebe5218362128, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：RNA 经验分享：请问下大家，版面费和published online，有先后顺序吗，是必须先缴费，才能给我文章online？我的只是发过来缴费邮件了，还没有看见online的邮件。我看我师妹的springer nature旗下某个期刊，是先online，然后30天内缴费，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5885600491, createdName=路过人间, createdTime=Wed Jan 24 09:59:43 CST 2024, time=2024-01-24, status=1, ipAttribution=江苏省)]

2023-07-11 ms4000001018877960 来自江苏省

这是被拒了吗，各位大佬。
Decision Sent to Author 10th Jul 23 11:06:21
Decision Made 7th Jul 23 17:45:06
Manuscript Under Consideration 28th Jun 23 11:12:00
Editor Assigned 26th Jun 23 03:06:10
Manuscript Received 26th Jun 23 03:06:10

55 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192675, encodeId=d23d21926e582, content=审稿速度:12.0 经验分享：2023年7月投稿 一审73天 二审（包含元旦）73天 临时接收到正式接收 29天 可以说很慢了，急着毕业不推荐 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e592182462, createdName=12077503m07(暂无昵称), createdTime=Tue Mar 12 01:03:15 CST 2024, time=2024-03-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185091, encodeId=6ca521850918c, content=审稿速度:1.0 经验分享：一篇综述原则性接收了总体来说挺快的 23.10.23 提交 23.10.24 第一次under consideration 23.11.13 第二次under consideration 23.11.18 Decision Made 23.11.20 send author 24.1.14 修回 24.1.15 第一次under consideration 24.1.15 第二次under consideration 24.1.26 Decision Made 24.1.30 原则性接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Wed Jan 31 20:04:17 CST 2024, time=2024-01-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：Cddise转投过来的，9天decision made，不知道是什么结果，这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147415, encodeId=da21214e41547, content=这是被拒了吗，各位大佬。 Decision Sent to Author 10th Jul 23 11:06:21 Decision Made 7th Jul 23 17:45:06 Manuscript Under Consideration 28th Jun 23 11:12:00 Editor Assigned 26th Jun 23 03:06:10 Manuscript Received 26th Jun 23 03:06:10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dd36413313, createdName=ms4000001018877960, createdTime=Tue Jul 11 08:11:13 CST 2023, time=2023-07-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1053865, encodeId=7e1b105386582, content=7月31号投稿，9月22号还在Manuscript Under Consideration，这速度真的不算快了，另外我同学也投的这个，连外审邮件都没收到，半个月就1审完了，真的神秘, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5daf5161008, createdName=146b8015m10(暂无昵称), createdTime=Wed Sep 22 17:23:02 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127820, encodeId=7873212e82037, content=审稿速度:6.0 经验分享：太慢了，着急毕业强烈不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f325294363, createdName=1486df0cm29(暂无昵称), createdTime=Sun Apr 23 13:38:58 CST 2023, time=2023-04-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2114337, encodeId=c0eb211433e5e, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：请问各位老师朋友，从从ccdisease 转投过来，第七天发邮件分配副编辑，现在第25天系统里没有出现zip包，请问现在是送外审没有呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8062163824, createdName=正宗椰汁, createdTime=Mon Feb 13 09:03:18 CST 2023, time=2023-02-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1225664, encodeId=3f32122566451, content=偏重的研究方向：机制 经验分享：请问大家，cell death disease被拒并提出了审稿意见，联系转投cell death discovery，是需要按照审稿意见修改之后再转投还是直接投啊，还需要再次送外审吗？🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac0c8174562, createdName=ms2000001143063837, createdTime=Fri Jun 10 14:57:16 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186052, encodeId=b34621860529f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问CDDisease一审转投的话会不会有容易中啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 05 19:34:04 CST 2024, time=2024-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183621, encodeId=ebe5218362128, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：RNA 经验分享：请问下大家，版面费和published online，有先后顺序吗，是必须先缴费，才能给我文章online？我的只是发过来缴费邮件了，还没有看见online的邮件。我看我师妹的springer nature旗下某个期刊，是先online，然后30天内缴费，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5885600491, createdName=路过人间, createdTime=Wed Jan 24 09:59:43 CST 2024, time=2024-01-24, status=1, ipAttribution=江苏省)]

2021-09-22 146b8015m10(暂无昵称)

7月31号投稿，9月22号还在Manuscript Under Consideration，这速度真的不算快了，另外我同学也投的这个，连外审邮件都没收到，半个月就1审完了，真的神秘

98 23

展开23条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192675, encodeId=d23d21926e582, content=审稿速度:12.0 经验分享：2023年7月投稿 一审73天 二审（包含元旦）73天 临时接收到正式接收 29天 可以说很慢了，急着毕业不推荐 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e592182462, createdName=12077503m07(暂无昵称), createdTime=Tue Mar 12 01:03:15 CST 2024, time=2024-03-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185091, encodeId=6ca521850918c, content=审稿速度:1.0 经验分享：一篇综述原则性接收了总体来说挺快的 23.10.23 提交 23.10.24 第一次under consideration 23.11.13 第二次under consideration 23.11.18 Decision Made 23.11.20 send author 24.1.14 修回 24.1.15 第一次under consideration 24.1.15 第二次under consideration 24.1.26 Decision Made 24.1.30 原则性接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Wed Jan 31 20:04:17 CST 2024, time=2024-01-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：Cddise转投过来的，9天decision made，不知道是什么结果，这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147415, encodeId=da21214e41547, content=这是被拒了吗，各位大佬。 Decision Sent to Author 10th Jul 23 11:06:21 Decision Made 7th Jul 23 17:45:06 Manuscript Under Consideration 28th Jun 23 11:12:00 Editor Assigned 26th Jun 23 03:06:10 Manuscript Received 26th Jun 23 03:06:10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dd36413313, createdName=ms4000001018877960, createdTime=Tue Jul 11 08:11:13 CST 2023, time=2023-07-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1053865, encodeId=7e1b105386582, content=7月31号投稿，9月22号还在Manuscript Under Consideration，这速度真的不算快了，另外我同学也投的这个，连外审邮件都没收到，半个月就1审完了，真的神秘, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5daf5161008, createdName=146b8015m10(暂无昵称), createdTime=Wed Sep 22 17:23:02 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127820, encodeId=7873212e82037, content=审稿速度:6.0 经验分享：太慢了，着急毕业强烈不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f325294363, createdName=1486df0cm29(暂无昵称), createdTime=Sun Apr 23 13:38:58 CST 2023, time=2023-04-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2114337, encodeId=c0eb211433e5e, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：请问各位老师朋友，从从ccdisease 转投过来，第七天发邮件分配副编辑，现在第25天系统里没有出现zip包，请问现在是送外审没有呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8062163824, createdName=正宗椰汁, createdTime=Mon Feb 13 09:03:18 CST 2023, time=2023-02-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1225664, encodeId=3f32122566451, content=偏重的研究方向：机制 经验分享：请问大家，cell death disease被拒并提出了审稿意见，联系转投cell death discovery，是需要按照审稿意见修改之后再转投还是直接投啊，还需要再次送外审吗？🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac0c8174562, createdName=ms2000001143063837, createdTime=Fri Jun 10 14:57:16 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186052, encodeId=b34621860529f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问CDDisease一审转投的话会不会有容易中啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 05 19:34:04 CST 2024, time=2024-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183621, encodeId=ebe5218362128, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：RNA 经验分享：请问下大家，版面费和published online，有先后顺序吗，是必须先缴费，才能给我文章online？我的只是发过来缴费邮件了，还没有看见online的邮件。我看我师妹的springer nature旗下某个期刊，是先online，然后30天内缴费，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5885600491, createdName=路过人间, createdTime=Wed Jan 24 09:59:43 CST 2024, time=2024-01-24, status=1, ipAttribution=江苏省)]

2023-04-23 1486df0cm29(暂无昵称) 来自重庆

审稿速度:6.0
经验分享：太慢了，着急毕业强烈不建议

33 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192675, encodeId=d23d21926e582, content=审稿速度:12.0 经验分享：2023年7月投稿 一审73天 二审（包含元旦）73天 临时接收到正式接收 29天 可以说很慢了，急着毕业不推荐 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e592182462, createdName=12077503m07(暂无昵称), createdTime=Tue Mar 12 01:03:15 CST 2024, time=2024-03-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185091, encodeId=6ca521850918c, content=审稿速度:1.0 经验分享：一篇综述原则性接收了总体来说挺快的 23.10.23 提交 23.10.24 第一次under consideration 23.11.13 第二次under consideration 23.11.18 Decision Made 23.11.20 send author 24.1.14 修回 24.1.15 第一次under consideration 24.1.15 第二次under consideration 24.1.26 Decision Made 24.1.30 原则性接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Wed Jan 31 20:04:17 CST 2024, time=2024-01-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：Cddise转投过来的，9天decision made，不知道是什么结果，这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147415, encodeId=da21214e41547, content=这是被拒了吗，各位大佬。 Decision Sent to Author 10th Jul 23 11:06:21 Decision Made 7th Jul 23 17:45:06 Manuscript Under Consideration 28th Jun 23 11:12:00 Editor Assigned 26th Jun 23 03:06:10 Manuscript Received 26th Jun 23 03:06:10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dd36413313, createdName=ms4000001018877960, createdTime=Tue Jul 11 08:11:13 CST 2023, time=2023-07-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1053865, encodeId=7e1b105386582, content=7月31号投稿，9月22号还在Manuscript Under Consideration，这速度真的不算快了，另外我同学也投的这个，连外审邮件都没收到，半个月就1审完了，真的神秘, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5daf5161008, createdName=146b8015m10(暂无昵称), createdTime=Wed Sep 22 17:23:02 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127820, encodeId=7873212e82037, content=审稿速度:6.0 经验分享：太慢了，着急毕业强烈不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f325294363, createdName=1486df0cm29(暂无昵称), createdTime=Sun Apr 23 13:38:58 CST 2023, time=2023-04-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2114337, encodeId=c0eb211433e5e, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：请问各位老师朋友，从从ccdisease 转投过来，第七天发邮件分配副编辑，现在第25天系统里没有出现zip包，请问现在是送外审没有呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8062163824, createdName=正宗椰汁, createdTime=Mon Feb 13 09:03:18 CST 2023, time=2023-02-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1225664, encodeId=3f32122566451, content=偏重的研究方向：机制 经验分享：请问大家，cell death disease被拒并提出了审稿意见，联系转投cell death discovery，是需要按照审稿意见修改之后再转投还是直接投啊，还需要再次送外审吗？🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac0c8174562, createdName=ms2000001143063837, createdTime=Fri Jun 10 14:57:16 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186052, encodeId=b34621860529f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问CDDisease一审转投的话会不会有容易中啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 05 19:34:04 CST 2024, time=2024-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183621, encodeId=ebe5218362128, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：RNA 经验分享：请问下大家，版面费和published online，有先后顺序吗，是必须先缴费，才能给我文章online？我的只是发过来缴费邮件了，还没有看见online的邮件。我看我师妹的springer nature旗下某个期刊，是先online，然后30天内缴费，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5885600491, createdName=路过人间, createdTime=Wed Jan 24 09:59:43 CST 2024, time=2024-01-24, status=1, ipAttribution=江苏省)]

2023-02-13 正宗椰汁来自陕西省

审稿速度:6.0 | 投稿命中率:50.0
经验分享：请问各位老师朋友，从从ccdisease 转投过来，第七天发邮件分配副编辑，现在第25天系统里没有出现zip包，请问现在是送外审没有呀？

32 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192675, encodeId=d23d21926e582, content=审稿速度:12.0 经验分享：2023年7月投稿 一审73天 二审（包含元旦）73天 临时接收到正式接收 29天 可以说很慢了，急着毕业不推荐 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e592182462, createdName=12077503m07(暂无昵称), createdTime=Tue Mar 12 01:03:15 CST 2024, time=2024-03-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185091, encodeId=6ca521850918c, content=审稿速度:1.0 经验分享：一篇综述原则性接收了总体来说挺快的 23.10.23 提交 23.10.24 第一次under consideration 23.11.13 第二次under consideration 23.11.18 Decision Made 23.11.20 send author 24.1.14 修回 24.1.15 第一次under consideration 24.1.15 第二次under consideration 24.1.26 Decision Made 24.1.30 原则性接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Wed Jan 31 20:04:17 CST 2024, time=2024-01-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：Cddise转投过来的，9天decision made，不知道是什么结果，这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147415, encodeId=da21214e41547, content=这是被拒了吗，各位大佬。 Decision Sent to Author 10th Jul 23 11:06:21 Decision Made 7th Jul 23 17:45:06 Manuscript Under Consideration 28th Jun 23 11:12:00 Editor Assigned 26th Jun 23 03:06:10 Manuscript Received 26th Jun 23 03:06:10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dd36413313, createdName=ms4000001018877960, createdTime=Tue Jul 11 08:11:13 CST 2023, time=2023-07-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1053865, encodeId=7e1b105386582, content=7月31号投稿，9月22号还在Manuscript Under Consideration，这速度真的不算快了，另外我同学也投的这个，连外审邮件都没收到，半个月就1审完了，真的神秘, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5daf5161008, createdName=146b8015m10(暂无昵称), createdTime=Wed Sep 22 17:23:02 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127820, encodeId=7873212e82037, content=审稿速度:6.0 经验分享：太慢了，着急毕业强烈不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f325294363, createdName=1486df0cm29(暂无昵称), createdTime=Sun Apr 23 13:38:58 CST 2023, time=2023-04-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2114337, encodeId=c0eb211433e5e, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：请问各位老师朋友，从从ccdisease 转投过来，第七天发邮件分配副编辑，现在第25天系统里没有出现zip包，请问现在是送外审没有呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8062163824, createdName=正宗椰汁, createdTime=Mon Feb 13 09:03:18 CST 2023, time=2023-02-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1225664, encodeId=3f32122566451, content=偏重的研究方向：机制 经验分享：请问大家，cell death disease被拒并提出了审稿意见，联系转投cell death discovery，是需要按照审稿意见修改之后再转投还是直接投啊，还需要再次送外审吗？🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac0c8174562, createdName=ms2000001143063837, createdTime=Fri Jun 10 14:57:16 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186052, encodeId=b34621860529f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问CDDisease一审转投的话会不会有容易中啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 05 19:34:04 CST 2024, time=2024-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183621, encodeId=ebe5218362128, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：RNA 经验分享：请问下大家，版面费和published online，有先后顺序吗，是必须先缴费，才能给我文章online？我的只是发过来缴费邮件了，还没有看见online的邮件。我看我师妹的springer nature旗下某个期刊，是先online，然后30天内缴费，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5885600491, createdName=路过人间, createdTime=Wed Jan 24 09:59:43 CST 2024, time=2024-01-24, status=1, ipAttribution=江苏省)]

2022-06-10 ms2000001143063837

偏重的研究方向：机制
经验分享：请问大家，cell death disease被拒并提出了审稿意见，联系转投cell death discovery，是需要按照审稿意见修改之后再转投还是直接投啊，还需要再次送外审吗？🙏

60 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192675, encodeId=d23d21926e582, content=审稿速度:12.0 经验分享：2023年7月投稿 一审73天 二审（包含元旦）73天 临时接收到正式接收 29天 可以说很慢了，急着毕业不推荐 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e592182462, createdName=12077503m07(暂无昵称), createdTime=Tue Mar 12 01:03:15 CST 2024, time=2024-03-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185091, encodeId=6ca521850918c, content=审稿速度:1.0 经验分享：一篇综述原则性接收了总体来说挺快的 23.10.23 提交 23.10.24 第一次under consideration 23.11.13 第二次under consideration 23.11.18 Decision Made 23.11.20 send author 24.1.14 修回 24.1.15 第一次under consideration 24.1.15 第二次under consideration 24.1.26 Decision Made 24.1.30 原则性接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Wed Jan 31 20:04:17 CST 2024, time=2024-01-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：Cddise转投过来的，9天decision made，不知道是什么结果，这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147415, encodeId=da21214e41547, content=这是被拒了吗，各位大佬。 Decision Sent to Author 10th Jul 23 11:06:21 Decision Made 7th Jul 23 17:45:06 Manuscript Under Consideration 28th Jun 23 11:12:00 Editor Assigned 26th Jun 23 03:06:10 Manuscript Received 26th Jun 23 03:06:10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dd36413313, createdName=ms4000001018877960, createdTime=Tue Jul 11 08:11:13 CST 2023, time=2023-07-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1053865, encodeId=7e1b105386582, content=7月31号投稿，9月22号还在Manuscript Under Consideration，这速度真的不算快了，另外我同学也投的这个，连外审邮件都没收到，半个月就1审完了，真的神秘, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5daf5161008, createdName=146b8015m10(暂无昵称), createdTime=Wed Sep 22 17:23:02 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127820, encodeId=7873212e82037, content=审稿速度:6.0 经验分享：太慢了，着急毕业强烈不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f325294363, createdName=1486df0cm29(暂无昵称), createdTime=Sun Apr 23 13:38:58 CST 2023, time=2023-04-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2114337, encodeId=c0eb211433e5e, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：请问各位老师朋友，从从ccdisease 转投过来，第七天发邮件分配副编辑，现在第25天系统里没有出现zip包，请问现在是送外审没有呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8062163824, createdName=正宗椰汁, createdTime=Mon Feb 13 09:03:18 CST 2023, time=2023-02-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1225664, encodeId=3f32122566451, content=偏重的研究方向：机制 经验分享：请问大家，cell death disease被拒并提出了审稿意见，联系转投cell death discovery，是需要按照审稿意见修改之后再转投还是直接投啊，还需要再次送外审吗？🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac0c8174562, createdName=ms2000001143063837, createdTime=Fri Jun 10 14:57:16 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186052, encodeId=b34621860529f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问CDDisease一审转投的话会不会有容易中啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 05 19:34:04 CST 2024, time=2024-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183621, encodeId=ebe5218362128, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：RNA 经验分享：请问下大家，版面费和published online，有先后顺序吗，是必须先缴费，才能给我文章online？我的只是发过来缴费邮件了，还没有看见online的邮件。我看我师妹的springer nature旗下某个期刊，是先online，然后30天内缴费，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5885600491, createdName=路过人间, createdTime=Wed Jan 24 09:59:43 CST 2024, time=2024-01-24, status=1, ipAttribution=江苏省)]

2024-02-05 ms5000001629270806 来自上海

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：请问CDDisease一审转投的话会不会有容易中啊

19 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192675, encodeId=d23d21926e582, content=审稿速度:12.0 经验分享：2023年7月投稿 一审73天 二审（包含元旦）73天 临时接收到正式接收 29天 可以说很慢了，急着毕业不推荐 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e592182462, createdName=12077503m07(暂无昵称), createdTime=Tue Mar 12 01:03:15 CST 2024, time=2024-03-12, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2185091, encodeId=6ca521850918c, content=审稿速度:1.0 经验分享：一篇综述原则性接收了总体来说挺快的 23.10.23 提交 23.10.24 第一次under consideration 23.11.13 第二次under consideration 23.11.18 Decision Made 23.11.20 send author 24.1.14 修回 24.1.15 第一次under consideration 24.1.15 第二次under consideration 24.1.26 Decision Made 24.1.30 原则性接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Wed Jan 31 20:04:17 CST 2024, time=2024-01-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2188162, encodeId=a0a321881622b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：Cddise转投过来的，9天decision made，不知道是什么结果，这也太快了吧😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 19 16:18:33 CST 2024, time=2024-02-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2147415, encodeId=da21214e41547, content=这是被拒了吗，各位大佬。 Decision Sent to Author 10th Jul 23 11:06:21 Decision Made 7th Jul 23 17:45:06 Manuscript Under Consideration 28th Jun 23 11:12:00 Editor Assigned 26th Jun 23 03:06:10 Manuscript Received 26th Jun 23 03:06:10, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dd36413313, createdName=ms4000001018877960, createdTime=Tue Jul 11 08:11:13 CST 2023, time=2023-07-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1053865, encodeId=7e1b105386582, content=7月31号投稿，9月22号还在Manuscript Under Consideration，这速度真的不算快了，另外我同学也投的这个，连外审邮件都没收到，半个月就1审完了，真的神秘, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5daf5161008, createdName=146b8015m10(暂无昵称), createdTime=Wed Sep 22 17:23:02 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127820, encodeId=7873212e82037, content=审稿速度:6.0 经验分享：太慢了，着急毕业强烈不建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f325294363, createdName=1486df0cm29(暂无昵称), createdTime=Sun Apr 23 13:38:58 CST 2023, time=2023-04-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2114337, encodeId=c0eb211433e5e, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：请问各位老师朋友，从从ccdisease 转投过来，第七天发邮件分配副编辑，现在第25天系统里没有出现zip包，请问现在是送外审没有呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8062163824, createdName=正宗椰汁, createdTime=Mon Feb 13 09:03:18 CST 2023, time=2023-02-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1225664, encodeId=3f32122566451, content=偏重的研究方向：机制 经验分享：请问大家，cell death disease被拒并提出了审稿意见，联系转投cell death discovery，是需要按照审稿意见修改之后再转投还是直接投啊，还需要再次送外审吗？🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac0c8174562, createdName=ms2000001143063837, createdTime=Fri Jun 10 14:57:16 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2186052, encodeId=b34621860529f, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问CDDisease一审转投的话会不会有容易中啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79419039130, createdName=ms5000001629270806, createdTime=Mon Feb 05 19:34:04 CST 2024, time=2024-02-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2183621, encodeId=ebe5218362128, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：RNA 经验分享：请问下大家，版面费和published online，有先后顺序吗，是必须先缴费，才能给我文章online？我的只是发过来缴费邮件了，还没有看见online的邮件。我看我师妹的springer nature旗下某个期刊，是先online，然后30天内缴费，谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5885600491, createdName=路过人间, createdTime=Wed Jan 24 09:59:43 CST 2024, time=2024-01-24, status=1, ipAttribution=江苏省)]

2024-01-24 路过人间来自江苏省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：RNA
经验分享：请问下大家，版面费和published online，有先后顺序吗，是必须先缴费，才能给我文章online？我的只是发过来缴费邮件了，还没有看见online的邮件。我看我师妹的springer nature旗下某个期刊，是先online，然后30天内缴费，谢谢大家

23 6

展开6条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务